Home / News / India News / Article / Biological E gets license for Ohio varsity's COVID-19 vaccine candidate

Biological E gets license for Ohio varsity's COVID-19 vaccine candidate

BE will be responsible for the evaluation and further development, including the commercialisation of the vaccine candidates

Listen to this article :
Picture used for representational purpose only

Picture used for representational purpose only

Biological E. Ltd, a Hyderabad-based vaccine and pharmaceutical company, and the Ohio State Innovation Foundation on Tuesday announced an exclusive license agreement for a Covid-19 vaccine technology.

The Ohio State Innovation Foundation has licensed novel live attenuated measles virus vectored vaccine candidates against SARS-CoV-2, which were developed by the Ohio State University College of Veterinary Medicine, exclusively to Biological E.

Trending Stories

Latest Photoscta-pos

Latest VideosView All

Latest Web StoriesView All

Mid-Day FastView All

Advertisement